Related Experiment Video
Updated: Mar 31, 2026

Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation
Published on: July 3, 2015
Radioprotective effect of mefenamic acid against radiation-induced genotoxicity in human lymphocytes
Seyed Jalal Hosseinimehr1, Reyhaneh Nobakht1, Arash Ghasemi2
1Department of Radiopharmacy, Faculty of Pharmacy, Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Purpose:
Mefenamic acid (MEF) as a non-steroidal anti-inflammatory drug is used as a medication for relieving of pain and inflammation. Radiation-induced inflammation process is involved in DNA damage and cell death. In this study, the radioprotective effect of MEF was investigated against genotoxicity induced by ionizing radiation in human blood lymphocytes.
Materials And Methods:
Peripheral blood samples were collected from human volunteers and incubated with MEF at different concentrations (5, 10, 50, or 100 µM) for two hours. The whole blood was exposed to ionizing radiation at a dose 1.5 Gy. Lymphocytes were cultured with mitogenic stimulation to determine the micronuclei in cytokinesis blocked binucleated lymphocyte.
Results:
A significant decreasing in the frequency of micronuclei was observed in human lymphocytes irradiated with MEF as compared to irradiated lymphocytes without MEF. The maximum decreasing in frequency of micronuclei was observed at 100 µM of MEF (38% decrease), providing maximal protection against ionizing radiation.
Conclusion:
The radioprotective effect of MEF is probably related to anti-inflammatory property of MEF on human lymphocytes.
Insights
Mefenamic acid (MEF) shows radioprotective effects against ionizing radiation in human lymphocytes. MEF significantly reduced radiation-induced DNA damage, with optimal protection observed at 100 µM concentration.
Area of Science:
- Pharmacology
- Radiation Biology
- Genetics
Background:
- Mefenamic acid (MEF) is a non-steroidal anti-inflammatory drug.
- Ionizing radiation induces inflammation, DNA damage, and cell death.
- Investigating radioprotective agents is crucial for mitigating radiation effects.
Purpose of the Study:
- To evaluate the radioprotective potential of MEF against genotoxicity induced by ionizing radiation.
- To assess the effect of MEF on DNA damage in human blood lymphocytes exposed to radiation.
Main Methods:
- Human peripheral blood lymphocytes were treated with varying concentrations of MEF (5–100 µM).
- The treated blood samples were exposed to 1.5 Gy of ionizing radiation.
- Micronuclei formation in binucleated lymphocytes was analyzed to quantify DNA damage.
Main Results:
- MEF treatment significantly decreased the frequency of radiation-induced micronuclei in lymphocytes.
- A dose-dependent protective effect was observed, with 100 µM MEF showing the maximum reduction (38%).
- MEF demonstrated significant radioprotective efficacy against ionizing radiation-induced genotoxicity.
Conclusions:
- MEF exhibits significant radioprotective properties in human lymphocytes.
- The anti-inflammatory action of MEF likely contributes to its radioprotective effect.
- MEF is a potential candidate for mitigating radiation-induced DNA damage.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mutagenicity and Carcinogenicity
Other Unique Bacteria

